Sign In
Buy SIGY
$0.0378
+0.0013 (+3.56%)
At Close: Jun 03, 2026
Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity
08:30am, Wednesday, 04'th Oct 2023
SAN DIEGO, CA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today di
Sigyn Therapeutics Reports Second Quarter 2023 Financial Results
04:30pm, Monday, 14'th Aug 2023
SAN DIEGO, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a medical technology company that creates blood purification devices to over
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
10:30am, Tuesday, 08'th Aug 2023
SAN DIEGO, CA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:SIGY), a medical technology company that creates blood purificat
Sigyn Therapeutics to Present at the Bullseye Small Cap Virtual Investor Conference
08:00am, Tuesday, 25'th Jan 2022
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused on the treatment of pathogen-related condition
Sigyn Therapeutics Featured on National Public Radio: “Addressing the Cytokine Storm”
07:30am, Monday, 30'th Aug 2021
SAN DIEGO, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets: SIGY), a medical technology company focused on the treatment of life-threatening inflammato
Sigyn Therapeutics, Inc. Announces Participation in the Q3 Virtual Investor Summit
07:29pm, Monday, 23'rd Aug 2021
San Diego, California--(Newsfile Corp. - August 23, 2021) - Sigyn Therapeutics, Inc. (OTC Pink: SIGY) today announced that Jim Joyce, Chairman & CEO will be attending the Q3 Virtual Investor Summit. �
Sigyn Therapeutics, Inc. Announces Participation in the Q3 Virtual Investor Summit
12:02pm, Tuesday, 17'th Aug 2021
San Diego, California--(Newsfile Corp. - August 17, 2021) - Sigyn Therapeutics, Inc. (OTC Pink: SIGY) today announced that Jim Joyce, Chairman & CEO will be attending the Q3 Virtual Investor Summit. �
Sigyn Therapeutics, Inc. Announces Participation in the Q3 Virtual Investor Summit
09:00am, Monday, 16'th Aug 2021
San Diego, California--(Newsfile Corp. - August 16, 2021) - Sigyn Therapeutics, Inc. (OTC Pink: SIGY) today announced that Jim Joyce, Chairman & CEO will be attending the Q3 Virtual Investor Summit. �
Sigyn Therapeutics CEO Note: A Treatment Candidate to Address Bloodstream Pathogens, Deadly Toxins and Inflammatory Disease Targets
06:30am, Tuesday, 10'th Aug 2021
SAN DIEGO, CA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets: SIGY), a medical technology company focused on the treatment of sepsis and other life-threa
Sigyn Therapeutics Announces Successful Completion of Animal Pilot Study
10:06am, Thursday, 29'th Jul 2021
SAN DIEGO, CA, July 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets: SIGY), a medical technology company focused on the treatment of life-threatening inflamma
Point Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - January 25, 2021) - Investorideas.com, a global news source and leading retail investor and trader resource issues a new CEO in
